Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study

Abstract

Among patients hospitalized with COVID-19, treatment with calcifediol, compared with those not receiving calcifediol, was significantly associated with lower in-hospital mortality during the first 30 days. The observational design and sample size may limit the interpretation of these findings.